Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Alx Oncology Holdings Inc
(NQ:
ALXO
)
1.510
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Alx Oncology Holdings Inc
< Previous
1
2
3
4
5
Next >
Why Delta Apparel Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
October 03, 2023
Gainers VIQ Solutions Inc. (NASDAQ: VQS) shares rose 88.5% to $0.2470 in pre-market trading after falling 18% on Monday. VIQ Solutions recently announced delisting from the Nasdaq.
Via
Benzinga
S&P 500, Nasdaq Futures Waver As Focus Turns To JOLTS Data: Why These Analysts Say Expecting A Strong Q4 This Year Is 'Tricky'
October 03, 2023
Index futures point to a modestly higher opening on Tuesday, while 10-year Treasury yields have surged to over 4.70%, adding to uncertainty about interest rates.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
ALX Oncology Reports Positive Interim Phase 2 ASPEN-06 Clinical Trial Results of Evorpacept for the Treatment of Advanced HER2-Positive Gastric Cancer
October 03, 2023
From
ALX Oncology
Via
GlobeNewswire
Where ALX Oncology Holdings Stands With Analysts
September 07, 2023
Via
Benzinga
4 Analysts Have This to Say About ALX Oncology Holdings
August 11, 2023
Via
Benzinga
What 4 Analyst Ratings Have To Say About ALX Oncology Holdings
May 12, 2023
Via
Benzinga
Recap: ALX Oncology Holdings Q1 Earnings
May 11, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
October 02, 2023
Via
Benzinga
ALX Oncology to Host Investor Call and Webcast on October 3, 2023 to Share Interim Phase 2 ASPEN-06 Clinical Trial Results of Evorpacept for the Treatment of Advanced HER2-Positive Gastric Cancer
October 02, 2023
From
ALX Oncology
Via
GlobeNewswire
Pathways to Progress: How Orphan Drug Designation Sparks Biotech Transformation
September 20, 2023
Via
Investor Brand Network
Exposures
Product Safety
Pathways to Progress: How Orphan Drug Designation Sparks Biotech Transformation
September 20, 2023
EQNX::TICKER_START (NASDAQ:GNPX),(OTCQX:RHHBY),(NASDAQ:JAZZ),(NASDAQ:ALXO),(NASDAQ:ACHL) EQNX::TICKER_END
Via
FinancialNewsMedia
Exposures
Product Safety
ALX Oncology Realigns Executive Leadership Team
September 06, 2023
From
ALX Oncology
Via
GlobeNewswire
ALX Oncology Announces September Investor Conference Participation
August 31, 2023
From
ALX Oncology
Via
GlobeNewswire
ALX Oncology Reports Second Quarter 2023 Financial Results and Provides Clinical Program Update
August 10, 2023
From
ALX Oncology
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
July 21, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
July 06, 2023
Via
Benzinga
Why Caribou Biosciences Shares Are Trading Higher By Around 58%? Here Are Other Stocks Moving In Thursday's Session
July 06, 2023
Gainers Caribou Biosciences, Inc. (NASDAQ: CRBU) shares jumped 58.1% to $6.45 after the company announced a $25 million equity investment from Pfizer.
Via
Benzinga
ALX Oncology Receives Orphan Drug Designation from the European Commission for Evorpacept for the Treatment of Patients with Gastric Cancer
June 26, 2023
From
ALX Oncology
Via
GlobeNewswire
ALX Oncology Reports First Quarter 2023 Financial Results and Provides Clinical Development and Operational Highlights
May 11, 2023
From
ALX Oncology
Via
GlobeNewswire
ALX Oncology Announces First Patient Dosed in Phase 2 Investigator-Sponsored Trial of Evorpacept in Patients with Ovarian Cancer
May 09, 2023
From
ALX Oncology
Via
GlobeNewswire
ALX Oncology Announces Clinical Trial Collaboration with Sanofi to Evaluate Evorpacept in Combination with SARCLISA (isatuximab-irfc) in Patients with Multiple Myeloma
April 25, 2023
From
ALX Oncology
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Intraday Session
April 21, 2023
Via
Benzinga
ALX Oncology and Quantum Leap Healthcare Collaborative™ Announce First Patient Dosed in the I-SPY-P1 TRIAL in Breast Cancer
March 13, 2023
From
ALX Oncology
Via
GlobeNewswire
Why SAP Shares Are Trading Higher By Around 6%? Here Are Other Stocks Moving In Friday's Mid-Day Session
April 21, 2023
Gainers Mangoceuticals, Inc. (NASDAQ: MGRX) shares jumped 207% to $2.84. The company announced Thursday, that it's featured on Webull Corporate Communications Service Platform.
Via
Benzinga
ALX Oncology Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Clinical Development and Operational Highlights and Upcoming Milestones
March 09, 2023
From
ALX Oncology
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Monday
April 03, 2023
On Monday, 76 companies set new 52-week lows.
Via
Benzinga
ALX Oncology Announces First Patient Dosed in ASPEN-07, a Phase 1 Study of Evorpacept for the Treatment of Patients with Urothelial Cancer
February 16, 2023
From
ALX Oncology
Via
GlobeNewswire
National Instruments, Virgin Galactic And Other Big Stocks Moving Higher On Friday
January 13, 2023
U.S. stocks traded slightly higher, with the Dow Jones gaining around 25 points on Friday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Why Bed Bath & Beyond Shares Are Trading Higher By 17%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
January 10, 2023
Gainers
Via
Benzinga
Super Micro Computer, Rayonier Advanced Materials And Some Other Big Stocks Moving Lower On Tuesday
January 10, 2023
U.S. stocks traded slightly higher, with the Dow Jones gaining around 30 points on Tuesday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.